Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial

Completed

Phase 4 Results

Summary of Purpose

The purpose of this study is to determine the effects of low-dose aspirin for the primary prevention of vascular events in patients with type 2 diabetes in Japan.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 22 September 2008.

1 Dec 2002 9 May 2005 1 May 2008 1 Jul 2008 1 Aug 2008 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Investigator, Outcomes Assessor)
  • Purpose: Prevention
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

Not available